MA25834A1 - Utilisation d'une combinaison de salmeterol et de propionate de fluticasone. - Google Patents

Utilisation d'une combinaison de salmeterol et de propionate de fluticasone.

Info

Publication number: MA25834A1
Authority: MA; Morocco
Prior art keywords: salmeterol; combination; fluticasone propionate; fluticasone; propionate
Prior art date: 2000-08-31

Application number

MA27058A

Other languages

English (en)

Inventor

Donald Herbert Horstman

Claire Julia Maden

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-31

Filing date

2003-02-27

Publication date

2003-07-01

2003-02-27 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2003-07-01 Publication of MA25834A1 publication Critical patent/MA25834A1/fr

Links

WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 title 1
229940021597 salmeterol and fluticasone Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Treatment Of Water By Ion Exchange (AREA)

MA27058A 2000-08-31 2003-02-27 Utilisation d'une combinaison de salmeterol et de propionate de fluticasone. MA25834A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US22938100P	2000-08-31	2000-08-31

Publications (1)

Publication Number	Publication Date
MA25834A1 true MA25834A1 (fr)	2003-07-01

Family

ID=22860986

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27058A MA25834A1 (fr)	2000-08-31	2003-02-27	Utilisation d'une combinaison de salmeterol et de propionate de fluticasone.

Country Status (24)

Country	Link
US (1)	US20040009963A1 (fr)
EP (1)	EP1313484A2 (fr)
JP (1)	JP2004507494A (fr)
KR (1)	KR20030031997A (fr)
CN (1)	CN1449288A (fr)
AP (1)	AP2003002753A0 (fr)
AR (1)	AR030516A1 (fr)
AU (1)	AU2001284236A1 (fr)
BG (1)	BG107596A (fr)
BR (1)	BR0113555A (fr)
CA (1)	CA2420532A1 (fr)
EA (1)	EA200300152A1 (fr)
EC (1)	ECSP034487A (fr)
HU (1)	HUP0303755A2 (fr)
IL (1)	IL154403A0 (fr)
MA (1)	MA25834A1 (fr)
MX (1)	MXPA03001752A (fr)
NO (1)	NO20030899L (fr)
OA (1)	OA12370A (fr)
PE (1)	PE20020387A1 (fr)
PL (1)	PL365582A1 (fr)
SK (1)	SK2302003A3 (fr)
WO (1)	WO2002017894A2 (fr)
ZA (1)	ZA200301475B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0106031D0 (en) *	2001-03-12	2001-05-02	Glaxo Group Ltd	Use
AU2003263717A1 (en) *	2002-09-25	2004-04-19	Astrazeneca Ab	A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
US20070071689A1 (en) *	2003-08-06	2007-03-29	Galephar M/F	Advantageous combination for inhalation of nacystelyn and bronchodilators
TR200907913A2 (tr) *	2009-10-20	2011-05-23	Bi̇lgi̇ç Mahmut	İnhalason yolu ile alınmak üzere kuru toz formunda farmasötik bileşim
US8834931B2 (en)	2009-12-25	2014-09-16	Mahmut Bilgic	Dry powder formulation containing tiotropium for inhalation
TR200909791A2 (tr) *	2009-12-25	2011-07-21	B�Lg�� Mahmut	Salmeterol ve flutikazon içeren farmasötik bileşim@
TR201000681A2 (tr) *	2010-01-29	2011-08-22	B�Lg�� Mahmut	İnhalasyon yoluyla alınan kuru toz formülasyonları.
US10111957B2 (en)	2012-07-05	2018-10-30	Arven Ilac Snayi ve Ticaret A.S.	Inhalation compositions comprising glucose anhydrous
US10105316B2 (en)	2012-07-05	2018-10-23	Arven llac Sanayi Ve Ticaret A.S.	Inhalation compositions comprising muscarinic receptor antagonist
WO2014007781A2 (fr) *	2012-07-05	2014-01-09	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Compositions d'inhalation
MX2015015132A (es) *	2013-04-29	2016-02-18	Sanofi Sa	Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
MA41378A (fr) *	2015-01-20	2017-11-28	Teva Branded Pharmaceutical Prod R & D Inc	Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol
GB202202297D0 (en)	2022-02-21	2022-04-06	Verona Pharma Plc	Formulation production process
CA3263546A1 (fr) *	2022-08-08	2024-02-15	Verona Pharma Limited	Ensifentrine (rpl-554) pour le traitement d’une bronchopneumopathie chronique obstructive modérée
CN121620356A (zh)	2023-06-26	2026-03-06	维罗纳制药公司	包含恩塞芬汀的颗粒组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL104068A (en) *	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9808802D0 (en) *	1998-04-24	1998-06-24	Glaxo Group Ltd	Pharmaceutical formulations
GB9924992D0 (en) *	1999-10-21	1999-12-22	Glaxo Group Ltd	Pharmaceutical aerosol formulations
US20030032632A1 (en) *	1999-12-24	2003-02-13	Crispps Leslie Alan	Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate

2001
- 2001-08-29 AR ARP010104122A patent/AR030516A1/es unknown
- 2001-08-29 PE PE2001000867A patent/PE20020387A1/es not_active Application Discontinuation
- 2001-08-31 WO PCT/GB2001/003928 patent/WO2002017894A2/fr not_active Ceased
- 2001-08-31 JP JP2002522868A patent/JP2004507494A/ja active Pending
- 2001-08-31 AP APAP/P/2003/002753A patent/AP2003002753A0/en unknown
- 2001-08-31 IL IL15440301A patent/IL154403A0/xx unknown
- 2001-08-31 MX MXPA03001752A patent/MXPA03001752A/es unknown
- 2001-08-31 SK SK230-2003A patent/SK2302003A3/sk unknown
- 2001-08-31 EA EA200300152A patent/EA200300152A1/ru unknown
- 2001-08-31 CN CN01814708A patent/CN1449288A/zh active Pending
- 2001-08-31 BR BR0113555-4A patent/BR0113555A/pt not_active Application Discontinuation
- 2001-08-31 EP EP01963205A patent/EP1313484A2/fr not_active Withdrawn
- 2001-08-31 AU AU2001284236A patent/AU2001284236A1/en not_active Abandoned
- 2001-08-31 US US10/363,438 patent/US20040009963A1/en not_active Abandoned
- 2001-08-31 PL PL01365582A patent/PL365582A1/xx not_active Application Discontinuation
- 2001-08-31 CA CA002420532A patent/CA2420532A1/fr not_active Abandoned
- 2001-08-31 KR KR10-2003-7002890A patent/KR20030031997A/ko not_active Withdrawn
- 2001-08-31 OA OA1200300054A patent/OA12370A/en unknown
- 2001-08-31 HU HU0303755A patent/HUP0303755A2/hu unknown
2003
- 2003-02-20 EC EC2003004487A patent/ECSP034487A/es unknown
- 2003-02-24 ZA ZA200301475A patent/ZA200301475B/en unknown
- 2003-02-26 NO NO20030899A patent/NO20030899L/no not_active Application Discontinuation
- 2003-02-27 BG BG107596A patent/BG107596A/bg unknown
- 2003-02-27 MA MA27058A patent/MA25834A1/fr unknown

Also Published As

Publication number	Publication date
PL365582A1 (en)	2005-01-10
EA200300152A1 (ru)	2003-08-28
SK2302003A3 (en)	2003-08-05
WO2002017894A2 (fr)	2002-03-07
AR030516A1 (es)	2003-08-20
KR20030031997A (ko)	2003-04-23
NO20030899D0 (no)	2003-02-26
ZA200301475B (en)	2004-05-24
IL154403A0 (en)	2003-09-17
OA12370A (en)	2004-03-19
US20040009963A1 (en)	2004-01-15
HUP0303755A2 (hu)	2004-04-28
PE20020387A1 (es)	2002-06-24
AU2001284236A1 (en)	2002-03-13
CN1449288A (zh)	2003-10-15
NO20030899L (no)	2003-04-28
BG107596A (bg)	2004-01-30
JP2004507494A (ja)	2004-03-11
ECSP034487A (es)	2003-03-31
MXPA03001752A (es)	2003-06-04
CA2420532A1 (fr)	2002-03-07
BR0113555A (pt)	2003-07-22
WO2002017894A3 (fr)	2002-08-08
EP1313484A2 (fr)	2003-05-28
AP2003002753A0 (en)	2003-06-30

Publication	Publication Date	Title
DE69936911D1 (de)	2007-10-04	Propofolhaltiges arzneimittel enthaltend sulfite
MA26891A1 (fr)	2004-12-20	Composes a fonction benzamido-piperidine et composes apparentes.
FR2816908B1 (fr)	2008-01-11	Unite d'embrayage
DE69940078D1 (de)	2009-01-22	Medizinische Schlauchverbindungsvorrichtung
PL360404A1 (pl)	2004-09-06	3'-proleki 2'-dezoksy-beta-L-nukleozydów
LU91429I2 (fr)	2008-06-16	"Furoate de fluticasone et ses solvates(AVAMYS)"
DE60115217D1 (de)	2005-12-29	Alprazolam inklusion-komplexe und ihre pharmazeutischen zusammensetzungen
DE69907423D1 (de)	2003-06-05	Druckdifferenzwandler
DE60140125D1 (de)	2009-11-19	Ertragenem inhalt
NL1013685A1 (nl)	2000-05-30	Verknopingsmiddel voor fotolaklaag en fotolaklaagsamenstelling welke deze omvat.
DE69838818D1 (de)	2008-01-17	Nicht weissanlaufende druckempfindliche emulsionsklebstoffe
NO20011562L (no)	2001-03-27	Integrert lydmikser
EP1084590A4 (fr)	2003-03-19	Ensemble capteur replie de type sagnac
BR9904942B1 (pt)	2008-11-18	mangueira.
DE10196021T1 (de)	2003-07-03	Universeller Vermögenswert- und Beziehungsmanager
BR0108414B1 (pt)	2011-01-25	utilização de um material e conduto.
FR2810555B1 (fr)	2003-05-30	Catheter reutilisable
PL365582A1 (en)	2005-01-10	Use of salmeterol and fluticasone propionate combination
DE60138858D1 (de)	2009-07-16	Kraftstoffschlauch- Anschlussstruktur und Kraftstoffschlauch
EP1286208A4 (fr)	2003-08-13	Detecteur d'image
EP1314428A4 (fr)	2006-10-18	Preparations d'oct
DE50107204D1 (de)	2005-09-29	8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
FR2809113B1 (fr)	2002-07-05	Films absorbeurs d'oxygene et structures comprenant ces films
IT1312284B1 (it)	2002-04-10	Tubo flessibile
IT1318654B1 (it)	2003-08-27	Composizioni farmaceutiche comprendenti agenti antiinfiammatori e lorousi.